Preview

Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations

Advanced search

THE ROLE OF GHRELIN IN CONTROL OF EMOTIONAL, EXPLORATIVE AND MOTOR BEHAVIOR IN EXPERIMENTAL POSTTRAUMATIC STRESS DISORDER

https://doi.org/10.25016/2541-7487-2018-0-1-65-74

Abstract

Relevance. Human survival in emergencies is often accompanied by the formation of post-traumatic stress disorder (PTSD) as a result of acute mental trauma.

Intention. To study behavioral signs of experimental posttraumatic stress disorder (PTSD) and effects of ghrelin and its antagonist in the experiments on rats exposed to an acute psychoemotional stress.

Methods. PTSD was modelled by placing a group of rats to a tiger python who seized and swallowed one of them, others experienced unescapable stress. Then ghrelin (20 µg in 20 µl) or its antagonist [D-Lys3]-GHRP-6 (10 µg in 20 µl) were administered intranasally daily for 7 days. On 7th day after stress and administration of drugs, the behavior of rats was studied using open field, elevated plus maze and intruder-resident tests.

Results and Discussion. Ghrelin antagonist [D-Lys3]-GHRP-6 demonstrated mainly anxiolytic effect (open field and intruder-resident tests) but increased behavior signs of python-induced stress in the elevated plus maze. At the same time, ghrelin did not alter PTSD signs (elevated plus maze) or exerted sedative (suppressive) action (open field and intruder-resident tests).

Conclusion. Therefore, the data support the involvement of ghrelin system in controlling motor and emotional behavior during PTSD development.

About the Authors

P. D. Shabanov
Institute of Experimental Medicine; Kirov Military Medical Academy
Russian Federation

Petr Dmitrievich Shabanov – Dr. Med. Sci. (Pharmacology) Prof., Head and Professor, Dept. of Pharmacology Kirov MMA; Anichkov Dept. of Neuropharmacology IEM.

6, Acad. Lebedev Str., St. Petersburg, 194044; 12, Acad. Pavlov Str., St. Petersburg, 197376

 



A. A. Lebedev
Institute of Experimental Medicine
Russian Federation

Andrei Andreevich Lebedev – Dr. Biol. Sci. (Pharmacology) Prof. Senior Researcher, Anichkov Dept. of Neuropharmacology.

12, Acad. Pavlov Str., St. Petersburg, 197376



V. I. Morozov
Institute of Experimental Medicine
Russian Federation

Vitalii Ivanovich Morozov – PhD (Therapy), Researcher, Anichkov Dept. of Neuropharmacology.

12, Acad. Pavlov Str., St. Petersburg, 197376



References

1. Vinogradov P.M., Tissen I.Yu., Lebedev A.A. [et al.]. Antagonist retseptorov grelina [D-Lys3]-GHRP-6 snizhaet ekspressiyu uslovnoi reaktsii predpochteniya mesta etanola u krys [Antagonist of ghrelin receptors [D-Lys3]-GHRP-6 reduces expression of place preference conditioned reaction of ethanol in rats]. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii [Reviews on clinical pharmacology and drug therapy]. 2015. Vol. 13, N 2. Pp. 27–33. (In Russ.)

2. Karpova I.V., Bychkov E.R., Tissen I.Yu. [et al.]. Vliyanie blokatora grelinovykh retseptorov [D-Lys3]-GHRP-6 na soderzhanie i obmen monoaminov v simmetrichnykh zonakh mozga krys, khronicheski potreblyavshikh alkogol’ [Effect of [D-Lys3]-GHRP-6, a blocker of ghrelin receptor, on the contents and turnover of monoamines in symmetrical zones of the brain of rats taking ethanol chronically]. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii [Reviews on clinical pharmacology and drug therapy]. 2017. Vol. 15, N 3. Pp. 48–56. (In Russ.)

3. Mikheev V.V., Shabanov P.D. Farmakologicheskaya asimmetriya mozga [Pharmacological asymmetry of the brain]. Sankt-Peterburg. 2007. 356 p. (In Russ.)

4. Khokhlov P.P., Tsikunov S.G., Tissen I.Yu. [i dr.] Effekty agonista i antagonista grelina na uroven’ endogennogo dezatsil-grelina v strukturakh limbicheskoi sistemy mozga pri psikhoemotsional’nom stresse u krys [Effects of both agonist and antagonist of ghrelin on the level of endogenous desacyl-ghrelin in structures of the limbic brain system in psychoemotional stress in rats]. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii [Reviews on clinical pharmacology and drug therapy]. 2017. Vol. 15, N 3. Pp. 22–27. (In Russ.)

5. Shabanov P.D., Vinogradov P.M., Lebedev A.A. [et al.]. Grelinovaya sistema mozga uchastvuet v kontrole emotsional’no-issledovatel’skogo povedeniya i dvigatel’noi aktivnosti krys, vyrashchennykh v usloviyakh stressa sotsial’noi izolyatsii [Ghrelin system of the brain participates in control of emotional and explorative behavior and motor activity of rats reared in conditions of social isolation stress]. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii [Reviews on clinical pharmacology and drug therapy]. 2017. Vol. 15, N 4. Pp. 38–45. (In Russ.)

6. Shabanov P.D., Vinogradov P.M., Lebedev A.A., Morozov V.I. Grelinovaya sistema mozga uchastvuet v kontrole emotsional’no-issledovatel’skogo povedeniya i dvigatel’noi aktivnosti krys, vyrashchennykh v usloviyakh stressa sotsial’noi izolyatsii [The brain ghrelin system participates in regulation of emotional and explorative behavior and motor activity in rats growing in conditions of social isolation stress]. Psikhicheskoe zdorov’e [The Russian mental health]. 2017. N 5. Pp. 3–11. (In Russ.)

7. Shabanov P.D., Morozov A.I., Lebedev A.A. Vliyanie grelina i ego antagonista [D-Lys3]-GHRP-6 na uslovnuyu reaktsiyu predpochteniya mesta etanola u khronicheski alkogolizirovannykh krys [Effect of ghrelin and its antagonist [D-Lys3]-GHRP-6 on the conditioned reaction of place preference of ethanol in chronically alcoholized rats]. Izvestiya Rossiiskoi Voenno-meditsinskoi akademii [Izvestiya of the Russian Military Medical Academy]. 2016. Vol. 35, N 4. Pp. 41–46. (In Russ.)

8. Yakushina N.D., Tissen I.Yu., Lebedev A.A. [et al.]. Vliyanie intranazal’no vvodimogo grelina na proyavleniya kompul’sivnogo povedeniya i uroven’ trevozhnosti u krys posle vital’nogo stressornogo vozdeistviya [Effects of intranasal ghrelin on both the compulsive behavior signs and anxiety level in rats following vital stressor exposure]. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii [Reviews on clinical pharmacology and drug therapy]. 2017. Vol. 15, N 3. Pp. 28–37. (In Russ.)

9. Abizaid A., Liu Z.W., Andrews Z.B. [et al.]. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 2006. Vol. 116, N 12. Pp. 3229.

10. Cabral A., Suescun O., Zigman J.M. [et al.]. Ghrelin indirectly activates hypophysiotropic CRF Neurons in rodents. PLoS One. 2012.

11. Carroll M.E., France C.P., Meisch R.A. Food-deprivation increases oral and intravenous drug intake in rats. Science. 1979. Vol. 205, N 4403. Pp. 319–321.

12. Chen Ch.-Y., Asakawa A., Fujimiya M. [et al.]. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol. Rev. 2009. N 61. Pp. 430–481.

13. Cummings D.E. Ghrelin and the shortand long-term regulation of appetite and body weight. Physiol. Behav. 2006. N 89. Pp. 71–84.

14. Dickson S.L., Leng G., Robinson I.C. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neurosci. 1993. N 53. Pp. 303–306.

15. Druce M.R., Wren A.M., Park A.J. [et al.]. Ghrelin increases food intake in obese as well as lean subjects. Int. J. Obesity (London). 2005. N 29. Pp. 1130–1136.

16. Egecioglu E., Jerlhag E., Salome N. [et al.]. Ghrelin increases intake of rewarding food in rodents. Addict. Biol. 2010. Vol. 15, N 3. P. 304–311.

17. Gnanapavan S., Kola B., Bustin S.A. [et al.]. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endo crinol. Metabolism. 2002. N 87. Pp. 2988.

18. Gualillo O., Caminos J.E., Nogueiras R. [et al.]. Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. Obesity Res. 2002. Vol. 10, N 7. Pp. 682–687.

19. Holsen L.M., Lawson E.A., Christensen K. [et al.]. Abnormal relationships between the neural response to highand low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa. Psychiatry Res. 2014. N 223. Pp. 94–103.

20. Howard A.D., Feighner S.D., Cully D.F. [et al.]. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996. Vol. 273, N 5277. Pp. 974–977.

21. Jerlhag E., Egecioglu E., Dickson S.L. et al. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict. Biol. 2011. Vol. 16, N 1. Pp. 82–91.

22. Kaur S., Ryabinin A.E. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotorurocortin-containing neurons. Alcoholism Clin. Exp. Res. 2010. Vol. 34, N 9. Pp. 1525–1534.

23. Kojima M., Hosoda H., Date Y. [et al.]. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999. N 402. Pp. 656–660.

24. Kroemer N.B., Krebs L., Kobiella A. [et al.]. Fasting levels of ghrelin covary with the brain response to food pictures. Addict. Biol. 2012. N 8. Pp. 855–862.

25. Lyons A.M., Lowery E.G., Sparta D.R. [et al.]. Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcoholism Clin. Exp. Res. 2008. Vol. 32, N 11. Pp. 1962–1968.

26. Patterson Z.R., Ducharme R., Anisman H., Abizaid A. Altered metabolic and neurochemical responses to chronic unpredictable stressors in ghrelin receptor-deficient mice. Eur. J. Neurosci. 2010. N 32. Pp. 632–639.

27. Perello M., Sakata I., Birnbaum S. [et al.]. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol. Psychiatry. 2010. Vol. 67, N 9. Pp. 880–886.

28. Zigman J.M., Jones J.E., Lee C.E. [et al.]. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 2006. Vol. 494, N 3. Pp. 528–548.


Review

For citations:


Shabanov P.D., Lebedev A.A., Morozov V.I. THE ROLE OF GHRELIN IN CONTROL OF EMOTIONAL, EXPLORATIVE AND MOTOR BEHAVIOR IN EXPERIMENTAL POSTTRAUMATIC STRESS DISORDER. Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations. 2018;(1):65-74. (In Russ.) https://doi.org/10.25016/2541-7487-2018-0-1-65-74

Views: 642


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4441 (Print)
ISSN 2541-7487 (Online)